Entry Clone Source: MGC |
Entry Clone Accession: BC052602 |
SGC Construct ID: CA13A-c003 |
GenBank GI number: gi|38348436 |
Entry Clone Source: MGC |
Entry Clone Accession: BC052602 |
SGC Construct ID: CA13A-c003 |
GenBank GI number: gi|38348436 |
Vector: pNIC28-Bsa4. Details [PDF ]; Sequence [ FASTA ] or [ GenBank ] |
Tags and additions: Tag sequence: N-terminal His-tag with a TEV protease cleavage site: mhhhhhhssgvdlgtenlyfq(*)sm |
Expressed sequence: |
Host: BL21(DE3)-R3-pRARE2 |
Expression protocol: Transformed 50 µl competent BL-21 (DE3)-R3-pRARE2 phage resistant cells with 6 µl of the plasmid DNA and plated out onto LB plate plus 50 µg/ml kanamycin and 35 µg/ml chloramphenicol. The next day colonies were picked out into fresh deep well blocks containing 1 ml TB + 50 µg/ml kanamycin and 35 µg/ml chloramphenicol which were grown overnight and glycerol stocks were prepared by adding 333 ml of 60 % glycerol to 1 ml of cell suspension, which were stored at -80°C to be used for future scale up preparations. |
Cell extraction: 2x Lysis buffer: 100 mM K-phosphate, pH 7.5, 1M NaCl, 1 mM TCEP, 1x Protease Inhibitors Cocktail Set VII (Calbiochem, 1/1000 dilution), and 15 units/ml Benzonase; Lysis buffer: 100 mM K-phosphate, pH 7.5, 1M NaCl, 1 mM TCEP. |
Procedure: Frozen cell pellets (17.36 g) were thawed briefly in water (20 - 37°C) then transferred to ice. One volume (i.e. 1 ml for every gram of cells) of 2x lysis buffer was added, followed by 1x lysis buffer to a total volume of 150 ml. The cells were resuspended by agitating and disrupted by high pressure homogenization (20 kpsi). Nucleic acids and cell debris were removed by adding 0.15% PEI (polyethyleneimine) from a 5% (w/v, pH 7.5) stock, stirring for 15 minutes, then centrifugation for 1 hour at 16,000 x g. The supernatant was then further clarified by filtration (Acrodisc filters, 0.2 µm). |
Column 1: Ni-affinity, HisTrap Crude FF, 5 ml (GE Healthcare) |
Solutions: Affinity buffer: 50 mM K-phosphate, pH 7.5, 500 mM NaCl, 10 mM imidazole, 0.5 mM TCEP; Wash buffer: 50 mM K-phosphate, pH 7.5, 500 mM NaCl, 30 mM imidazole, 0.5 mM TCEP; Elution buffer: 50 mM K-phosphate, pH 7.5, 500 mM NaCl, 300 mM imidazole, 0.5 mM TCEP. |
Procedure: The cell extract was loaded on the column at 4 ml/minute on an AKTA-express system (GE Healthcare). The column was washed with 10 volumes of lysis buffer, 10 volumes of wash buffer, and then eluted with elution buffer at 4 ml/min. The eluted peak of A280 was automatically collected. |
Column 2: Gel filtration, Hiload 16/60 Superdex S75 prep grade, 120 ml (GE Healthcare) |
GF buffer: 10 mM HEPES, pH 7.5, 500 mM NaCl, 5% Glycerol, 0.5 mM TCEP, 4 mM MgCl2. |
Procedure: The eluted fraction from the Ni-affinity Histrap column was loaded on the gel filtration column in GF buffer at 0.80 ml/min. Eluted proteins were collected in 2-ml fractions and analyzed on SDS-PAGE. |
Mass spec characterization: ESI-MS revealed that the protein had a mass of 31862 Da (expected mass: 31859). |
Protein concentration: 24 mg/ml in gel filtration buffer using a centricon with a 10kDa cut off. The protein concentration was determined spectrophotometrically using ε280= 51910. |
Crystallization: Crystals were grown by vapour diffusion from nanolitre sitting drops at 4°C. The protein was mixed with a reservoir solution containing 32% (w/v) PEG 3350, 0.013403M Citric acid and 0.086597M Na-Citrate (pH5.2) (75 nl protein:75 nl solution), and allowed to equilibrate by vapour diffusion. |
Data Collection, Resolution: 2.05 Å , X-ray source: Synchrotron SLS-X10SA, single wavelength. |